The in vivo distribution of iron between the binding sites of transferrin was examined. Plasma was obtained from normal subjects under basal conditions and after in vitro and in vivo iron loading. Independent methods, including measurement of the transferrin profile after isoelectric focusing and cross immunoelectrophoresis, and determination of the iron content in the separated fractions were in agreement that there was a random distribution of iron on binding sites. This held true with in vitro loading, when iron was increased by intestinal absorption and with loading from the reticuloendothelial system. The 
Transferrin is the iron transport protein of the plasma and mediates iron exchange between tissues. The question of whether its two binding sites serve different functional roles has lead to abundant but contradictory literature (1, 2) . A heterogeneous behavior of the plasma iron pool could lead to a selective release of iron from one site, a selective loading of the two sites, or a combination of these. Recent studies failed to reveal functional differences in iron release between the two sites (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) . Instead, a competitive advantage of difemc transferrin over the two monoferric forms in delivering iron was apparent (13, 14) . Were there a process which could adjust the generation of diferric vs. monoferric transferrin, it would have major implications for the regulation of internal iron exchange.
MATERIALS AND METHODS
Fresh heparinized plasma samples were obtained from normal adults after an overnight fast. Loading of plasma with iron above basal levels was achieved in vitro by adding ferrous sulfate (4, 6) and in vivo either through intestinal absorption after oral ingestion of 100 mg of iron as ferrous ascorbate (molar ratio Fe/ascorbate = 1:5) or from the reticuloendothelial system through hemolysis induced by oral ingestion of 300 mg of niacin (15, 16) . In both in vivo loading studies, plasma samples were obtained at basal levels of saturation and at 20-min intervals for up to 6 hr after drug ingestion. These plasma samples were trace-labeled by the addition of 125I-labeled apotransferrin or with 59Fe.
Labeling of transferrin with 1251 was carried out by the iodine monochloride procedure of McFarlane (17) with modifications as described (5, 6) . To 4 ml of the plasma to be analyzed was added 0.2 ,uCi (1 Ci = 37 GBq) of 125I-apotransferrmn (specific activity, 0.4 mCi/mg of protein). The 59Fe was added as ferrous sulfate (0.1 ,uCi in 0.1 ml of 0.01 M HCl (specific activity, 10 ,uCi/,tg of Fe), to the same 4 ml of plasma. The mixture was incubated for 10 min at 370C and thereafter stored at 40C.
Electrophoresis in the presence of 6 M urea was based on the separation principle described by Makey and Seal (18) , and crossed immunoelectrophoresis was based on the procedures described by Weeke and Soderholm et al. (19, 20) . The replacement of polyacrylamide by Sea Kem LE agarose (FMC, Marine Colloid Division, Rockland, ME) gave better separation and required less manipulation than did the system described by Leibman and Aisen (21) . This particular type of agarose will gel even in the presence of 6 M urea. Reagents were prepared with deionized water and further treated with a chelating resin (Chelex 100, Bio-Rad) to remove any residual contaminating iron (22) . The 10 M urea stock solution was mixed for 5 hr with bed resin (50 g/liter; AG501-X8, Bio-Rad), filtered, and stored at 40C. The barbital buffer (0.1 M, pH 8.6) was mixed (5 g/liter) with Chelex 100 and then filtered. In the actual procedure, a mixture of 45 ml of 10 M urea, 35 ml of 0.1 M barbital buffer, and 0.75 g of Sea Kem LE agarose was heated to boiling. We poured the gel in a cold room (2°C) using a precooled leveling table in a humidity chamber. A volume of 16.5 ml of gel per 110 x 102.5 mm sheet of agarose gel support medium (Gel Bond film, FMC, Rockland, ME) was used. The gel was then transferred to a flat bed electrophoresis cell (model 1415 BioRad) and blotted thoroughly with filter paper. By using a sample application foil (LKB, Bromma, Sweden), the plasma sample (4) was applied 3 cm from the left side of the gel and 2.5 cm from the bottom edge and was allowed to absorb for 15 min. In order to monitor electrophoretic movement, 4 ,ul of concentrated human hemoglobin (about 10 mg/ml) containing bromthymol blue was applied in a similar position on the right side of the gel.
Electrophoresis was run in the usual manner with 0.05 M barbital buffer (pH 8.6) in the buffer chamber. The cell was kept at 10°C, and the voltage gradient was adjusted to 10 V/cm. After approximately 6 hr, the hemoglobin marker migrated to a position of 2-3 cm from the far edge of the gel. At this time, the electrophoresis was stopped, and the gel was removed from the cell. A cut was made 3.3 cm from the left edge, and the gel to the right was peeled away and discarded. The gel-bond film underneath was rinsed with deionized water and wiped dry to remove residual urea. Thirteen milliliters of a 0.02 M barbital buffer containing 1% Sea Kem agarose (which had been dissolved by boiling) was cooled to 55°C, mixed with 50 ,ud or rabbit anti-human transferrin serum (23) , and poured on the bare side of the gel-bond film. Care was taken that the antibody-containing gel was in close contact with the urea gel but did not cover parts of that gel. The gel system was returned to the cell, and immunoelectrophoresis was started in the second dimension at 16°C at a voltage gradient of 2 V/cm. The gel was pressed, washed, dried, and stained following the recommendations of the Bio-Rad brochure (24) . The profile obtained was copied on bond paper, and the cutout of each peak [diferric, acid-stable Abbreviations: AL, acid labile; AS, acid stable.
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For isoelectric focusing, 0.24-ml aliquots were taken and applied on 7.5% preparative polyacrylamide columns (1.5 x 18 cm 2% Ampholine (LKB), pH 5-8). The separation was carried out as described (5, 6, 14) , and 2-mm gel slices were measured for radioactivity and transferrin content by rocket immunoelectrophoresis (19) . Nearly complete elution of protein (>95%) out of the gel slices was achieved by adding 0.5 ml of 1 M barbital buffer (pH 8.6) to each gel slice and allowing the mixture to stand in the cold room for 2-3 days. The transferrin content of the supernatant was determined by rocket immunoelectrophoresis; a standard curve was obtained with human diferric transferrin or apotransferrin with no apparent differences.
Another way of examining the distribution of transferrin iron was by determining the iron content of the three ironcontaining species after isoelectric focusing. For this purpose, 5-ml aliquots taken from seven subjects were pooled (serum iron, 120 ,g/dl; total iron binding capacity, 300 ,ug/dl) and tagged with 59Fe as described above. The transferrin fraction was partially purified by using affinity chromatography (column 2.5 x 60 cm; filled with Affi-Gel Blue, Bio-Rad) to remove the albumin. Special care was taken to minimize iron contamination in the buffer by using Chelex 33% 100 (5 g per 1000 ml of 0.01 M bicarbonate-buffered saline, pH 7.4) (Bio-Rad) and by washing the column with 200 mg of desferrioxamine dissolved in 5 ml of water prior to sample application. After chromatography, the transferrin fractions were pooled (total volume, 80 ml) and concentrated to a volume of 1.5 ml in an ultrafiltration cell (model 8MC, PM 10 filter; Amicon). A 1-ml aliquot of the concentrate was applied on the isoelectric focusing system (5, 6, 14) . After the gel was separated and cut, 2 ml of 1 M HCl04 was added to each slice. The slice was shaken for 20 hr in a water bath, after which the total iron and radioactivity were determined (4, 25) .
Plasma iron and transferrin saturations were determined by standard methods (25, 26) and verified by spectrophometric saturation technique (27) . The mathematical formula used to describe the "random model" for iron binding to the two binding sites on transferrin have been described elsewhere (22, 28) . The methods of incubation, washing, wet ashing, iron determination and quantification of radioactivity were the same as described (3) (4) (5) (6) .
Variations in the results of multiple determinations are expressed throughout as ± 1 SD.
RESULTS
Plasma samples drawn from seven healthy fasting subjects with a known serum iron concentration and transferrin satu- Crossed immunoelectrophoresis of transferrin in normal human plasma. The transferrin saturation varied between 14% and 48%, and 4-,l plasma samples from four male and three female subjects were applied (see Table 1 ). Analysis of the pattern is presented in Fig. 2 . (Table 1) were analyzed by urea gel electrophoresis in combination with immunoelectrophoresis. The separation patterns of the four molecular forms of human transferrin (apo-diferric, AS monoferric, and AL monoferric transferrins) obtained after staining are presented in Fig. 1 . Consistently all four peaks were observed. The separation between apo-and diferric transferrins was complete, whereas there was some overlap between the two monofemc species and of apotransferrin with the AS monoferric species. By using a simple weighing method, it was possible to approximate the area under the four molecular transferrin forms (Fig. 2) . Although the general distribution appears to follow that predicted by random distribution (ratio of AL/AS monoferric transferrins = 1.1 + 0.2; n = 7), there were greater amounts of both mono-and diferric transferrins at low transferrin saturations than would have been predicted from the original transferrin saturations (Table 1 ; Fig. 2 ).
Because of our concern that the small sample size of 4-,p1 of plasma used in urea electrophoresis would inevitably lead to difficulties caused by iron contamination, isoelectric focusing was used, which permitted a sample size 100 times larger. This had the additional advantage of giving a better separation of the four molecular species of human transferrin. An additional benefit is the fact that the large separation capacity allows simultaneous determination of the transferrin content and of the amount of iron bound to the various forms of transferrin (Fig. 3) . A profile of the iron and iodine peaks of a single subject's plasma and of the protein content of the peaks as determined by immunoelectrophoresis is shown in Fig. 3 a and b . No 1251 was found in the position of the iron-loaded forms, indicating that there had been no exchange among the transferrin molecules during sample preparation and isoelectric focusing (Fig. 3a) .
In order to determine the iron content of the mono-and diferric transferrin peaks directly, a pooled plasma sample was concentrated and subjected to isoelectric focusing, and the iron content of the individual peaks was analyzed directly (Fig. 3c) . The partition of the iron between the monoferric and diferric transferrin plasma pool correlated well with that expected on the basis of random loading. The monoferric transferrin value of 58% corresponded to a theoretical value of 60% and, the diferric transferrin value determined to be 42% was in essential agreement with the theoretical value of 40%. Furthermore, the chemically determined iron distribution between the mono-and diferric transferrins of 58% and 42%, respectively, was in agreement with the distribution of radioiron between these two species of transferrin of 57% and 43% (Fig. 3d) . This validated the determination of transferrin iron distribution by trace labeling with radioiron. The similar distribution of the radioiron of the unconcentrated as compared to the concentrated sample (57%/43% vs. 55%/ 45%) indicated that the concentration procedure had not altered the iron distribution (Fig. 3 c and d) .
On the basis of this information, the plasma samples of the seven subjects on the study were trace-labeled with 59FeSO4 and spiked with a trace amount of 125I-labeled human transferrin as an additional way to monitor possible scrambling of iron before or during the separation process. The basal transferrin saturations were between 14% and 48% ( Table 1) . Excellent correlation (r > 0.90) was obtained between results of these analyses and values predicted by the random distribution of iron as a function of transferrin saturation ( Table 1) . The protein data determined by immunoelectrophoresis are presented in Fig. 4a . The distribution of apo-, monoferric, and diferric transferrins under basal conditions was compared with the distribution expected on the basis of random loading. Shown in Fig. 4b , a subject was given an oral loading dose of iron that resulted in an increase in transferrin saturation from the basal value of 20% to approximately 60%. In Fig. 4c is shown the change in distribution with saturation increasing from 46% to 80% because of niacin-induced hemolysis. The data obtained with in vitro loading of plasma containing only apotransferrin by iron is shown in Fig. 4d . In all of these studies, reasonable agreement was found between the demonstrated values and the values predicted by the random distribution model. It has been speculated that it originated as the result of a gene duplication and fusion from a primitive Mr 40,000 monoferric-sited ancestral protein (1, 2) . Biochemists and physiologists have speculated on the evolutionary advantage of such a duplication. While there is every reason to assume that a Mr of >60,000 was necessary to prevent loss through a filtration kidney (29) , the advantage of having two iron binding sites on the molecule was less obvious.
Recent work has clarified the iron-donating behavior of the transferrin molecule. The two separable and chemically distinct monoferric forms of transferrin (AS and AL) have been shown to have identical iron-donating capacities, both in animals and in humans (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) . In addition, iron release from any form of transferrin to erythroid cells was found to be an "all or none" phenomenon, generating only apotransferrin (5) (6) (7) (8) (9) (10) (11) . The most important feature is a competitive advantage of diferric over monoferric transferrin in delivering iron to reticulocytes (13) . In the human system, this amounts to a 7-fold advantage, but similar competitive advantages were observed in other homologous systems, including the rabbit and the rat (4, 22) .
There is less information and agreement concerning iron loading of the transferrin molecule (1, 2, 21, 30, (32) (33) (34) . There are two types of information: those relating to the in vivo distribution of iron on transferrin of normal subjects under basal conditions (21) and those relating to states of iron loading in vitro and in vivo (32, 33 (21, 30, 31) . Other studies with gastrointestinal iron loading in animals have produced variable results (4, 32, 33) . In an attempt to clarify this, a variety of methods have been used in our laboratory. Problems leading to erroneous identification included faulty buffer composition, the use of chelates in the buffer that could mediate iron exchange among iron-binding sites, technical problems with the immunoelectrophoretic procedure, and iron contamination particularly (5, 21, 34, 35) . The limited sample volume of 4 ul of plasma that is usually applied to the Mackey Seal system makes iron contamination extremely likely (5, 35) . In retrospect, there appeared to be some contamination in our studies using this technique despite all efforts to prevent it (see Fig. 2 ). Prior efforts to increase the amount of transferrin that can be applied to the urea gel system have included the purification of transferrin, usually involving some dialysis followed by various concentration steps (30, 34) . These manipulations are prone to change the distribution of iron as originally presented in native plasma. Contaminating iron, buffer effects due to iron chelation, and even the ionic salt concentration in the buffer system were found to affect the distribution of iron between the NH2 and COOH-terminal binding sites of the molecule (34, 36, 37) . Only by applying a large volume of plasma in the isoelectric focusing system and running the separation from alkaline to more acid pH (4, 5) were we able to obtain reproducible results.
The conclusion that the in vivo distribution of apo-, monoferric, and diferric transferrins was random in normal subjects was reached in several different ways. Most directly, it was shown by direct analysis of the iron content of the different fractions separated by isoelectric focusing. Second, the distribution of a trace amount of radioiron added to the plasma was identical to the distribution by iron analysis and to the predicted random distribution based on the transferrin saturation. Third, the protein content of the transferrin peaks was that predicted on the basis of random distribution. Finally, the ratio between the two monoferric species in normal subjects was 1.1 ( Fig. 1 and Table 1 ).
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From these results it is now possible to characterize both the uptake and release of iron from transferrin as it occurs in vivo. The random loading produces a predictable relationship between the monoferric and difemc transferrins according to the transferrin saturation. The preferential tissueuptake of diferric transferrin iron means that as plasma iron increases, tissue uptake also will increase to counteract the increase in plasma iron concentration. The converse will occur with a decreased input of iron into circulation. Thus, there is an autoregulation of plasma iron concentration due to the monoferric/diferric effect.
